Predicting cancer progression
    1.
    发明申请
    Predicting cancer progression 审中-公开
    预测癌症进展

    公开(公告)号:US20070141650A1

    公开(公告)日:2007-06-21

    申请号:US10555935

    申请日:2004-05-14

    IPC分类号: G01N33/574 G06F19/00

    摘要: The present invention involves early prediction of progression of a cancer disease in patients treated for cancer. According to the invention the binding response level of an immunoreactive material (IM) comprising thymidine kinase 1 (TK1) protein is determined in a body fluid sample of a patient and the likelihood of progress of the cancer disease is estimated based directly on this determined IM binding response level. Those patients that run a risk of cancer progress and tumor relapse 1-15 years after the cancer treatment may be identified directly by the IM binding response level according to the invention within a few months following initiation of the treatment.

    摘要翻译: 本发明涉及对癌症患者中癌症疾病进展的早期预测。 根据本发明,在患者的体液样品中测定包含胸苷激酶1(TK1)蛋白的免疫反应性物质(IM)的结合应答水平,并且直接基于所确定的IM估计癌症疾病进展的可能性 绑定响应级别。 患癌症进展风险的患者和癌症治疗后1-15年的肿瘤复发可以在治疗开始后的几个月内通过本发明的IM结合反应水平直接鉴定。